Health Canada issues NOC to J&J’s CARVYKTI for multiple myeloma

Health Canada has issued a Notice of Compliance (NOC) for Johnson & Johnson’s (J&J) CARVYKTI for multiple myeloma treatment.

Nov 23, 2024 - 06:00

Health Canada issues NOC to J&J’s CARVYKTI for multiple myeloma

Health Canada has issued a Notice of Compliance (NOC) for Johnson & Johnson’s (J&J) CARVYKTI for multiple myeloma treatment.

Read the original article

Tags:

Previous Article

“No magic wand” for Novo Nordisk, as CagriSema pen supply rumours swirl

Europe’s TCR immunotherapy licensing deals surge 123% above US in 2024

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: BMS, looking to build a market for a heart drug, turns to a Viz.ai algorithm to detect disease

STAT+: BMS, looking to build a market for a heart drug,...

Aug 15, 2023

Amgen in artificial intelligence: theme innovation stra...

Mar 5, 2024

Texas Medical Board under pressure to define emergency exception to abortion ban

Texas Medical Board under pressure to define emergency ...

Feb 3, 2024